Boai NKY Medical Holdings Ltd. (SHE:300109)

Market Cap	9.25B +29.0%
Revenue (ttm)	1.45B -2.8%
Net Income	239.53M -40.0%
EPS	0.48 -42.2%
Shares Out	486.05M
PE Ratio	39.28
Forward PE	n/a
Dividend	0.25 (1.31%)
Ex-Dividend Date	Jul 10, 2025

Volume	6,124,029
Average Volume	14,239,014
Open	18.89
Previous Close	19.03
Day's Range	18.89 - 19.25
52-Week Range	12.75 - 21.11
Beta	0.02
RSI	49.36
Earnings Date	Apr 24, 2026

About Boai NKY Medical Holdings

Boai NKY Medical Holdings Ltd. engages in the fine chemical and precision medicine businesses in China and internationally. The company produces and sells polyvinyl pyrrolidone (PVP), Orarez, and in vitro diagnostic products, as well as invests in tumor drugs. It offers its products for pharmaceutical products, such as APIs and excipients; personal care products, including cosmetics, haircare, oral care, and household care; alcohol, soft drinks, and food; battery, petroleum and natural gas, and photovoltaic; and membrane, textile and dyeing, ag...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1987
• Employees: 1,163
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300109

Financial Performance

In 2024, Boai NKY Medical Holdings's revenue was 1.61 billion, an increase of 1.45% compared to the previous year's 1.58 billion. Earnings were 349.68 million, a decrease of -29.07%.